Drug
Omacetaxine Mepesuccinate
Omacetaxine Mepesuccinate: highest development phase Phase 1/2, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Omacetaxine mepesuccinate NCT02078960 | Phase 1/2 | Chronic Myeloid Leukemia |
Latest
No recent events.
Follow Omacetaxine Mepesuccinate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.